Date Range
toReport Types
Condition
See all (38)
Region of the Body
See all (16)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Network meta-analysis of effects of leukocyte-poor & -rich PRP in knee OA treatment
Am J Sports Med. 2016 Mar;44(3):792-800
Leukocyte-poor PRP may improve outcomes following arthroscopy for knee osteoarthritis
Arch Orthop Trauma Surg. 2015 Jul;135(7):971-7.
Leukocyte-poor PRP effective and safe versus placebo for symptomatic knee OA treatment
Am J Sports Med. 2016 Apr;44(4):884-91
Leukocyte-poor platelet-rich plasma vs hyaluronic acid in treatment of symptomatic knee OA
Am J Sports Med. 2017 Feb;45(2):339-346
Both PRP and HA injections improve pain and function in early knee OA compared to saline
Knee Surg Sports Traumatol Arthrosc. 2017 Mar;25(3):958-965
A systematic review of PRP in the treatment of lateral epicondylitis
Arthroscopy. 2013 Nov;29(11):1851-62
PRP injection therapy for chronic lateral epicondylar tendinopathy
Br J Sports Med. 2014 Jun;48(12):952-6
The effect of platelet-rich plasma on outcomes following ACL reconstruction
Arthroscopy. 2015 May;31(5):981-988.
Role of PRP in single segment posterior lumbar interbody fusion
Eur Spine J; 2011; 20(10):1650-1657
PRP does not improve tendon structure in chronic midportion Achilles tendinopathy patients
Br J Sports Med. 2011 Apr;45(5):387-92. doi: 10.1136/bjsm.2010.076398. Epub 2010 Nov 3
PRP reduces retear rate post arthroscopic rotator cuff repair, but is not cost-effective
Am J Sports Med. 2015 Dec;43(12):3071-6.
PRP reduces donor site knee pain in bone-patellar tendon-bone ACL reconstruction
Knee Surg Sports Traumatol Arthrosc. 2012 Jan;20(1):114-20. doi: 10.1007/s00167-011-1570-5. Epub 2011 Jun 16
Platelet-Rich Plasma vs. Novel Cross-linked Hyaluronic Acid Injection for Early Knee Osteoarthritis
Medicina (Kaunas). 2022 Aug 1;58(8):1028. doi: 10.3390/medicina58081028.. 2022 01-Aug;():. 10.3390/medicina58081028
Small-medium sized rotator cuff tears may benefit from PRP application
PLoS One. 2013 Jul 12;8(7):e69731. doi: 10.1371/journal.pone.0069731. Print 2013